Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in ... Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services. The company serves the biotechnology and biopharmaceutical industries. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in San Antonio, Texas. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0011 | 100 | 0.0011 | 0.0022 | 0.0011 | 417 | 0.0012 | CS |
| 4 | 0.0001 | 4.7619047619 | 0.0021 | 0.03 | 0.001 | 5262 | 0.00127412 | CS |
| 12 | -0.0078 | -78 | 0.01 | 0.048 | 0.0002 | 9741 | 0.00503023 | CS |
| 26 | 0.0012 | 120 | 0.001 | 0.1 | 0.0002 | 21351 | 0.01119561 | CS |
| 52 | -0.04723 | -95.549261582 | 0.04943 | 0.15 | 0.0001 | 21186 | 0.0172238 | CS |
| 156 | -0.0268 | -92.4137931034 | 0.029 | 4.2 | 0.0001 | 272366 | 0.03149706 | CS |
| 260 | -0.0268 | -92.4137931034 | 0.029 | 4.2 | 0.0001 | 272366 | 0.03149706 | CS |
JRyan
3分前
stock king 1
6分前
stock king 1
7分前
erg61
10分前
Frank69OH
11分前
moczowy
21分前
jimr1717
46分前
peafunke
48分前
GameStop
53分前
Ranb2khz
53分前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。